Thomas Dahlberg, DO
Pain Medicine · Rockford, ILNPI 1801856380
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 77.2% of it on its own, with 49 other manufacturers making up the rest. Reporting peaked in 2021 at $60,716 and has fallen 61.8% since, to $23,201 in 2025. Among pain medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 878 payments — averaging $247.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$168K
- Vertex$18K
- Boston Scientific$7K
- Abbott$6K
- Trevena, Inc.$5K
- Globus Medical$3K
- plus $11K from 44 others
What the payments were for
- Consulting fees$40,75319%
- Speaking & faculty fees$118,87055%
- Travel & lodging$36,77417%
- Food & beverage$21,30910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$68,357
- Senza Spinal Cord Stimulation System$55,163
- Senza$42,218
- JOURNAVX$17,706
- GENERAL PAIN MANAGEMENT$6,255
- PROCLAIM$4,722
- Olinvyk$4,578
- Evoke$2,215
- Prospera$270
- ETERNA$262
- INTELLIS ADAPTIVESTIM$146
- BIOTRONIK$146
- Iovera$125
- QULIPTA$125
- UBRELVY$125
- Proclaim IPG$114
- Intracept RF Probe$105
How this compares
$217,705 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 265 | $4,076 |
| Fentanyl | 41 | $3,757 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 154 | $3,715 |
| Pregabalin | 83 | $1,863 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $1,025 |
| Celecoxib | 56 | $703 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $682 |
| Oxycodone Hcl | 13 | $519 |
| Tramadol Hcl | 95 | $466 |
| Methylprednisolone | 92 | $353 |
| Cyclobenzaprine Hcl | 50 | $336 |
| Cephalexin | 59 | $263 |
| Meloxicam | 116 | $247 |
| Duloxetine Hcl | 13 | $234 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $230 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rockford
- Frederick GahlRockford$12K
- Zachary BelfordRockford$11K
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.